SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-036497
Filing Date
2023-10-06
Accepted
2023-10-06 16:05:25
Documents
1
Period of Report
2023-10-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13226
  Complete submission text file 0001493152-23-036497.txt   14977
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 917-970-1730
COMMODORE CAPITAL LP (Reporting) CIK: 0001831942 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 231314248